Purdue To Hold Off On Oxycontin Generics Until Federal Circuit Ruling

Law360, New York (May 18, 2004, 12:00 AM EDT) -- Generics maker Endo Pharmaceuticals has decided to hold off on launching its 10mg, 20mg and 40mg strengths oxycodone extended-release tablets until after an appellate rules in its litigation with The Purdue Frederick Co. over Oxycontin patents.

“The Company remains confident that the District Court decision declaring Purdue's OxyContin patents invalid will be affirmed by the Federal Circuit Court. The Company will continue to monitor the situation and may in the future decide to launch its oxycodone extended-release tablets in advance of the appellate court decision,” the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.